MRI-based Biomarkers for Predicting Punctate White Matter Lesions in Neonates

NCT02637817 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 600

Last updated 2018-06-28

No results posted yet for this study

Summary

As a common white matter (WM) disease in preterm neonates, punctate white matter lesion (PWML) frequently leads to the abnormalities of brain development (e.g. the motor, visual and auditory disorders), even to cerebral palsy (CP) and amblyopia during childhood. However, it is lack of certain methods in identifying the prognosis of PWML. Through using various advanced MRI techniques, neuro-behavioral and visual assessments, a multicenter longitudinal study would be conducted to follow-up the PWML neonates with varying spatial-position and degree lesions. Through tracking the variations in WM microstructures from neonate period to childhood (2 years old and 3 years old), this study aims to explore (1) the potential relations between varying PWMLs and motor and visual disorders (2) the relations between WM MRI-metrics and neurodevelopmental assessment results, and thus determine the early biomarkers to identify CP and amblyopia.

Conditions

  • Brain Diseases
  • Amblyopia
  • Brain Damage, Chronic
  • Cerebral Palsy

Sponsors & Collaborators

  • Shenzhen Children's Hospital

    collaborator OTHER_GOV
  • General Hospital of Ningxia Medical University

    collaborator OTHER
  • Xijing Hospital

    collaborator OTHER
  • Shengjing Hospital

    collaborator OTHER
  • Second Affiliated Hospital of Wenzhou Medical University

    collaborator OTHER
  • Zunyi Medical College

    collaborator OTHER
  • Shaanxi Provincial People's Hospital

    collaborator OTHER
  • Baoji Central Hospital

    collaborator OTHER
  • Children's Hospital of Fudan University

    collaborator OTHER
  • Hainan People's Hospital

    collaborator OTHER
  • First Affiliated Hospital Xi'an Jiaotong University

    lead OTHER

Eligibility

Min Age
1 Day
Max Age
28 Days
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2016-01-31
Primary Completion
2019-06-30
Completion
2019-12-31

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02637817 on ClinicalTrials.gov